In vivo emergence of cefiderocol and ceftazidime/avibactam cross-resistance in KPC-producing Klebsiella pneumoniae following ceftazidime/avibactam -based therapies.
Diagn Microbiol Infect Dis
; 110(1): 116372, 2024 Sep.
Article
in En
| MEDLINE
| ID: mdl-38875893
ABSTRACT
We described the emergence of ceftazidime/avibactam and cefiderocol cross-resistance in patients with KPC-producing Klebsiella pneumoniae infections. All strains with ceftazidime/avibactam and cefiderocol cross-resistance showed point mutations on KPC Ω-loop. Taken together, our results indicate that prolonged exposure to ceftazidime/avibactam can confer cross-resistance to ceftazidime/avibactam and cefiderocol.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Beta-Lactamases
/
Klebsiella Infections
/
Microbial Sensitivity Tests
/
Ceftazidime
/
Cephalosporins
/
Drug Resistance, Multiple, Bacterial
/
Drug Combinations
/
Azabicyclo Compounds
/
Cefiderocol
/
Klebsiella pneumoniae
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Diagn Microbiol Infect Dis
/
Diagn. microbiol. infect. dis
/
Diagnostic microbiology and infectious disease
Year:
2024
Document type:
Article
Affiliation country:
Italia
Country of publication:
Estados Unidos